Joanna I. Clarke
Liverpool, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Establishing reference ranges for circulating biomarkers of drug-induced liver injury in healthy human volunteers.
Journal: British journal of clinical pharmacology
Published: June 12, 2024
WITHDRAWN: Reference intervals for putative biomarkers of drug-induced liver injury and liver regeneration in healthy human volunteers.
Journal: Journal of hepatology
Published: October 20, 2017
Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies.
Journal: The lancet. Gastroenterology & hepatology
Published: February 20, 2017
Circulating levels of miR-122 increase post-mortem, particularly following lethal dosing with pentobarbital sodium: implications for pre-clinical liver injury studies.
Journal: Toxicology research
Published: December 13, 2016
Novel circulating- and imaging-based biomarkers to enhance the mechanistic understanding of human drug-induced liver injury.
Journal: Journal of clinical and translational research
Published: November 09, 2016
Recent advances in biomarkers and therapeutic interventions for hepatic drug safety - false dawn or new horizon?
Journal: Expert opinion on drug safety
Published: March 01, 2016
A novel high mobility group box 1 neutralizing chimeric antibody attenuates drug-induced liver injury and postinjury inflammation in mice.
Journal: Hepatology (Baltimore, Md.)
Published: November 02, 2015
Redox-Dependent HMGB1 Isoforms as Pivotal Co-Ordinators of Drug-Induced Liver Injury: Mechanistic Biomarkers and Therapeutic Targets.
Journal: Antioxidants & redox signaling
Published: October 21, 2015
Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis.
Journal: Toxicology and applied pharmacology
Published: November 27, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026